Primary membranous nephropathy (MN) is a kidney-specific autoimmune disease that is a major cause of nephrotic syndrome. The autoimmune nature of pMN was first discovered upon the identification of antibodies to the phospholipase A2 receptor (PLA2R). Antibodies to PLA2R occur in 70% to 80% of patients with pMN and have been shown to have a high diagnostic value. Recent guidelines for the management of glomerular diseases have highlighted the importance of anti-PLA2R antibody detection for pMN diagnosis, monitoring, and transplant evaluation. In this webinar, Dr. Laurence Beck introduces the pathogenesis of pMN, and highlights the role of anti-PLA2R and other biomarkers in pMN diagnosis and monitoring.
Laurence Beck, MD, PhD
Associate Professor, Nephrology
Boston University School of Medicine
To view this webinar, please complete the following form.
2024 EUROIMMUN US
